Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,709.60
(
0.00%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.35
(
-2.73%
)
Bitcoin
70,075.55
(
-1.81%
)
News Focus
News Focus
Post# of 519040
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23229
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: Investor2014 post# 207630

Wednesday, 08/28/2019 9:24:16 PM

Wednesday, August 28, 2019 9:24:16 PM

Post# of 519040
I2014 Maybe I have this wrong, but as I understand it the trial with the 6 18 -45 year olds was to show that 2-73 is well tolerated by Rett patients. There was an efficacy component to the trial also.

Now that trial is close to over, if not over, they are recruiting the younger patients in the larger trial.

If I have this wrong please correct me.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News